Breakthrough T1D Launches Third Center of Excellence in New England
The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by the immune system after transplantation.
The Girl Who Won’t Back Down From Type 1 Diabetes
My daughter Gia was playing organized sports for the first time. A leading scorer in basketball like her dad, a 14-year NBA veteran, she was excited to play. Until there was a change. Gia was lethargic. She vomited every day, had an unquenchable thirst, and started wetting the bed. This continued for a couple of […]
She Had a Wish: Donate to Science
When Cheryl Diderich died, her husband knew she wanted to live on through his gift of $1.2 million to Breakthrough T1D, to fund the research of Jon Odorico, M.D.
T1D Voices: Reagan’s Story Is Our Story
T1D Champion Reagan Moore shares her T1D journey, her hopes for the future, and why she loves her insulin pump.
Can a Psoriasis Drug Halt or Reverse Type 1 Diabetes?
Type 1 diabetes is one of the only major autoimmune diseases that doesn't have a disease-modifying therapy. A Breakthrough T1D clinical trial is aiming to change that.
Special Diabetes Program (SDP) Renewed for Three Years!
One of Breakthrough T1D’s top legislative priorities has been achieved with the enactment of a three-year renewal of the Special Diabetes Program (SDP). The program, now funded until September 30, 2023 at $150 million per year, will enable researchers to build upon the momentum in type 1 diabetes (T1D) to date and explore new opportunities […]
Delay on Rule That Would Eliminate Medicare Part D Drug Rebates
On January 29, 2021, the Biden Administration delayed implementation of a recently adopted rule that would largely eliminate drug rebates in Medicare Part D. This rule had not yet been implemented and was scheduled to go into effect in 2022. This delay is part of the Biden Administration’s broader freeze on all regulations recently adopted […]
Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).
Timothy Doyle Joins Breakthrough T1D as President and Chief Operating Officer
Doyle will lead organizational operations to broaden Breakthrough T1D’s reach and impact.
Department of Health & Human Services Freezes Rule Related to Insulin
As you may have heard from reports in the media the Biden Administration froze a recent regulation on insulin. Want to know what the headlines mean? Read on to get all the details. On January 21, the Biden Administration placed a freeze on all newly published regulations set forth by the previous Administration that had not yet been implemented. This includes a regulation that will require community health […]
